Rensselaer team receives NIAID grant to develop antiviral drug for Covid-19
Pharmaceutical Technology
JUNE 28, 2022
grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. The team’s work will be based on the prior research of Structural Bioinformatics Constellation Endowed chair Dr Montelione.
Let's personalize your content